Table 3.
Univariate regression analysis for parameters associated with CD4+ cell recovery within the first year of cART
| Variable | N | Univariate analysis | |
|---|---|---|---|
| OR (95% CI) | p value | ||
| Total participants | 301 | ||
| CD4+ cell count at baseline (cells/µl) | |||
| < 100 | 89 | 0.383 (0.190–0.773) | 0.006* |
| 100–200 | 38 | 1.262 (0.579–2.750) | 0.559 |
| 201–350 | 119 | 0.729 (0.414–1.285) | 0.275 |
| > 350 | 55 | 3.554 (1.903–6.639) | < 0.001* |
| Sex | |||
| Male | 234 | 0.915 (0.816–1.107) | 0.499 |
| Female | 67 | 1.184 (0.732–1.915) | 0.503 |
| CMV DNA positive | 35 | 1.282 (0.506–3.252) | 0.600 |
| EBV DNA positive | 74 | 1.019 (0.527–1.968) | 0.956 |
| HHV-8 DNA positive | 29 | 0.790 (0.320–1.950) | 0.608 |
Odds ratios (ORs) and 95% confidence intervals (CIs) for the selected parameters CD4+ cell count at baseline, sex and CMV, EBV and HHV8 DNA detection in correlation to CD4+ cell recovery within the first year of cART (*: statistically significant correlation)